MiNK Therapeutics, Inc. Property, Plant and Equipment
MiNK Therapeutics, Inc. (INKT) had Property, Plant and Equipment of $318.47 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-13
- 2026-06-30: Property, Plant and Equipment, Net $318.47K.
- 2026-03-31: Property, Plant and Equipment, Net $354.52K.
- 2025-12-31: Property, Plant and Equipment, Net $390.87K.
- 2025-09-30: Property, Plant and Equipment, Net $429.34K.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $318.47K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $354.52K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $390.87K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $429.34K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $473.21K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $687.50K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $732.93K 10-K · filed 2026-03-31 |
| 2024-09-30 | $799.52K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $849.96K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $894.99K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $953.98K 10-K · filed 2025-03-18 |
| 2023-09-30 | $991.46K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.06M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.07M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.07M 10-K · filed 2024-03-21 |
| 2022-09-30 | $803.13K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $787.54K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $665.21K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $606.60K 10-K · filed 2023-03-24 |
| 2021-09-30 | $635.89K 10-Q · filed 2021-11-29 |
| 2020-12-31 | $458.38K 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |